ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Xin Li
Matched on ORCID iD 0000-0003-1594-2378; OpenAlex author ID A5006838958. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2025: 2 papers · 2026: 2 papers
Papers 4
- Luteolin Triggers Pyroptosis in Pancreatic Ductal Adenocarcinoma by Inhibiting Mitochondrial Fission through the RAS/ERK/DRP1 Pathway. First author DOI 10.1142/s0192415x26500606↗
- Bufalin Suppresses Pancreatic Ductal Adenocarcinoma Through ER Stress-Ferroptosis Crosstalk Associated with IP3R-Linked Ca2+ Dysregulation and ATF3/SLC7A11 Reg… First author DOI 10.3390/ijms27104373↗
- Alpha-Heredin targets CAMKⅡ/DRP1-Mediated mitochondrial fission to trigger ferroptosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.phymed.2025.157048↗
- Modified Sijunzi Decoction Inhibits Pancreatic Cancer Progression and Improves Immune Suppression: Network Pharmacology and Experimental Validation. Co-author DOI 10.2147/dddt.s520390↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Waimei Si · 4 shared papers, 2025–2026 · strength 1.18
- Paper Bufalin Suppresses Pancreatic Ductal Adenocarcinoma Through ER Stress-Ferroptosis Crosstalk Associated with IP3R-Linked… DOI 10.3390/ijms27104373↗
- Paper Luteolin Triggers Pyroptosis in Pancreatic Ductal Adenocarcinoma by Inhibiting Mitochondrial Fission through the RAS/ER… DOI 10.1142/s0192415x26500606↗
- Paper Alpha-Heredin targets CAMKⅡ/DRP1-Mediated mitochondrial fission to trigger ferroptosis in pancreatic ductal adenocarcin… DOI 10.1016/j.phymed.2025.157048↗
- Peiwen Yang · 4 shared papers, 2025–2026 · strength 1.18
- Paper Bufalin Suppresses Pancreatic Ductal Adenocarcinoma Through ER Stress-Ferroptosis Crosstalk Associated with IP3R-Linked… DOI 10.3390/ijms27104373↗
- Paper Luteolin Triggers Pyroptosis in Pancreatic Ductal Adenocarcinoma by Inhibiting Mitochondrial Fission through the RAS/ER… DOI 10.1142/s0192415x26500606↗
- Paper Alpha-Heredin targets CAMKⅡ/DRP1-Mediated mitochondrial fission to trigger ferroptosis in pancreatic ductal adenocarcin… DOI 10.1016/j.phymed.2025.157048↗
- Yuan Zhang · 3 shared papers, 2025–2026 · strength 0.87
- Paper Luteolin Triggers Pyroptosis in Pancreatic Ductal Adenocarcinoma by Inhibiting Mitochondrial Fission through the RAS/ER… DOI 10.1142/s0192415x26500606↗
- Paper Alpha-Heredin targets CAMKⅡ/DRP1-Mediated mitochondrial fission to trigger ferroptosis in pancreatic ductal adenocarcin… DOI 10.1016/j.phymed.2025.157048↗
- Paper Modified Sijunzi Decoction Inhibits Pancreatic Cancer Progression and Improves Immune Suppression: Network Pharmacology… DOI 10.2147/dddt.s520390↗
- He Ba · 3 shared papers, 2025–2026 · strength 0.87
- Paper Luteolin Triggers Pyroptosis in Pancreatic Ductal Adenocarcinoma by Inhibiting Mitochondrial Fission through the RAS/ER… DOI 10.1142/s0192415x26500606↗
- Paper Alpha-Heredin targets CAMKⅡ/DRP1-Mediated mitochondrial fission to trigger ferroptosis in pancreatic ductal adenocarcin… DOI 10.1016/j.phymed.2025.157048↗
- Paper Modified Sijunzi Decoction Inhibits Pancreatic Cancer Progression and Improves Immune Suppression: Network Pharmacology… DOI 10.2147/dddt.s520390↗
- Linjie Ruan · 3 shared papers, 2025–2026 · strength 0.87
- Paper Luteolin Triggers Pyroptosis in Pancreatic Ductal Adenocarcinoma by Inhibiting Mitochondrial Fission through the RAS/ER… DOI 10.1142/s0192415x26500606↗
- Paper Alpha-Heredin targets CAMKⅡ/DRP1-Mediated mitochondrial fission to trigger ferroptosis in pancreatic ductal adenocarcin… DOI 10.1016/j.phymed.2025.157048↗
- Paper Modified Sijunzi Decoction Inhibits Pancreatic Cancer Progression and Improves Immune Suppression: Network Pharmacology… DOI 10.2147/dddt.s520390↗
- Zhen Chen · 2 shared papers, 2025–2026 · strength 0.58
- Paper Luteolin Triggers Pyroptosis in Pancreatic Ductal Adenocarcinoma by Inhibiting Mitochondrial Fission through the RAS/ER… DOI 10.1142/s0192415x26500606↗
- Paper Modified Sijunzi Decoction Inhibits Pancreatic Cancer Progression and Improves Immune Suppression: Network Pharmacology… DOI 10.2147/dddt.s520390↗
- Zhen Chen · 1 shared paper, 2026 · strength 0.32
- Xiaoyan Zhu · 1 shared paper, 2026 · strength 0.32
- Lixia Yi · 1 shared paper, 2026 · strength 0.30
- Zhen Chen · 1 shared paper, 2025 · strength 0.28
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.